/
SLP
$18.38+$0.18 (+0.99%)prev close
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$367.9M
20M shares
52-week range
$11.09 – $21.01
73% from low
Sector
SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN
Exchange
NASDAQ
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-37.28
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $29.7M | $34.0M | $41.6M | $46.5M | $53.9M | $59.6M | $70.0M | $79.2M |
| Cost of revenue | $8.0M | $9.0M | $10.6M | $10.6M | $10.8M | $11.6M | $26.9M | $33.0M |
| Gross profit | $21.7M | $24.9M | $30.9M | $35.9M | $43.1M | $47.9M | $43.2M | $46.2M |
| Gross margin | 73.1% | 73.4% | 74.4% | 77.2% | 79.9% | 80.5% | 61.6% | 58.4% |
| R&D | $1.8M | $2.5M | $3.0M | $4.0M | $3.2M | $4.5M | $5.8M | $6.9M |
| Operating income | $10.3M | $10.6M | $11.6M | $11.3M | $14.9M | $8.7M | $6.1M | −$70.7M |
| EBITDA | $13.0M | $13.3M | $14.3M | $14.7M | $18.7M | $13.1M | $18.1M | $14.7M |
| Net income | $8.9M | $8.6M | $9.3M | $9.8M | $12.5M | $10.0M | $10.0M | −$64.7M |
| Net margin | 30.1% | 25.3% | 22.4% | 21.1% | 23.2% | 16.7% | 14.2% | -81.7% |
| EPS (diluted) | 0.50 | 0.48 | 0.50 | 0.47 | 0.60 | 0.49 | 0.49 | -3.22 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $82M | $0.87 | $0.81–$0.92 | 3 |
| 2027 | $86M | $0.91 | $0.90–$0.91 | 3 |
| 2028 | $93M | $1.06 | $1.05–$1.07 | 1 |
| 2029 | $103M | $1.28 | $1.27–$1.29 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$21.26
Price
$18.38
Implied upside
+16%
Peer comparison
Simulations Plus, Inc.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
www.simulations-plus.com- Employees
- 213
- IPO / List date
- Jun 18, 1997
- HQ
- RESEARCH TRIANGLE PARK, NC
Held by traders on TradeandTell
No one on the platform currently holds SLP.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 181,500 | $2.1M |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 1.31% ($0.24/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2024-07-29 | $0.0600 | 2024-08-05 |
| 2024-04-26 | $0.0600 | 2024-05-06 |
| 2024-01-26 | $0.0600 | 2024-02-05 |
| 2023-10-27 | $0.0600 | 2023-11-06 |
| 2023-07-28 | $0.0600 | 2023-08-07 |
Stock splits
| Execution date | Ratio |
|---|---|
| 2007-10-02 | 2-for-1 |
| 2006-08-14 | 2-for-1 |
Recent trades on TradeandTell
No one on the platform has traded SLP yet.
